This is a table of type unigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
unigram | frequency |
---|---|
patients | 22160 |
cells | 15059 |
blood | 14461 |
cell | 13773 |
cd | 11241 |
hla | 7196 |
results | 6744 |
study | 5915 |
disease | 5586 |
donor | 5490 |
donors | 5389 |
transfusion | 5377 |
anti | 5059 |
group | 5026 |
using | 4988 |
i | 4850 |
transplantation | 4571 |
treatment | 4452 |
one | 4346 |
high | 4318 |
patient | 4215 |
median | 4158 |
also | 4093 |
hsct | 4026 |
days | 4012 |
used | 3992 |
may | 3934 |
time | 3892 |
years | 3862 |
two | 3832 |
data | 3822 |
risk | 3792 |
day | 3772 |
analysis | 3752 |
gvhd | 3695 |
response | 3651 |
transplant | 3641 |
specific | 3624 |
immune | 3591 |
associated | 3552 |
methods | 3548 |
clinical | 3435 |
stem | 3272 |
human | 3269 |
positive | 3199 |
expression | 3174 |
months | 3108 |
infection | 3092 |
il | 3059 |
acute | 3039 |
performed | 2991 |
received | 2944 |
non | 2917 |
compared | 2912 |
age | 2828 |
antigen | 2825 |
based | 2821 |
vs | 2803 |
platelet | 2789 |
system | 2787 |
protein | 2739 |
pts | 2737 |
cases | 2698 |
number | 2689 |
significant | 2662 |
survival | 2660 |
mice | 2657 |
respectively | 2635 |
post | 2628 |
studies | 2619 |
different | 2617 |
use | 2614 |
however | 2584 |
peptide | 2581 |
first | 2579 |
virus | 2578 |
antibodies | 2574 |
therapy | 2569 |
samples | 2536 |
well | 2523 |
range | 2521 |
levels | 2485 |
found | 2472 |
epitopes | 2435 |
observed | 2426 |
graft | 2394 |
plasma | 2376 |
related | 2375 |
higher | 2367 |
severe | 2355 |
ml | 2342 |
increased | 2309 |
antibody | 2298 |
mg | 2286 |
mhc | 2279 |
class | 2255 |
showed | 2252 |
due | 2251 |
background | 2251 |
allogeneic | 2237 |
peptides | 2233 |
ii | 2201 |
significantly | 2197 |
control | 2193 |
low | 2159 |
year | 2151 |
type | 2138 |
kg | 2128 |
relapse | 2111 |
negative | 2059 |
binding | 2033 |
total | 2019 |
treated | 1990 |
responses | 1987 |
conditioning | 1978 |
viral | 1970 |
groups | 1953 |
dose | 1942 |
without | 1937 |
vaccine | 1917 |
units | 1892 |
test | 1829 |
hiv | 1813 |
incidence | 1803 |
three | 1787 |
case | 1779 |
following | 1762 |
including | 1747 |
method | 1745 |
population | 1742 |
red | 1736 |
chronic | 1735 |
reported | 1734 |
will | 1716 |
within | 1709 |
antigens | 1681 |
conclusions | 1678 |
recipients | 1669 |
epitope | 1668 |
development | 1659 |
gene | 1657 |
new | 1656 |
role | 1642 |
identified | 1619 |
factors | 1617 |
conclusion | 1600 |
sars | 1598 |
level | 1592 |
present | 1588 |
effect | 1587 |
developed | 1575 |
follow | 1575 |
rate | 1568 |
overall | 1557 |
single | 1556 |
marrow | 1555 |
among | 1552 |
reduced | 1546 |
infections | 1545 |
testing | 1537 |
bone | 1530 |
cmv | 1524 |
potential | 1522 |
donation | 1520 |
sct | 1517 |
pre | 1501 |
allo | 1499 |
host | 1494 |
rbc | 1493 |
induced | 1491 |
table | 1491 |
activation | 1476 |
shown | 1466 |
proteins | 1464 |
mortality | 1464 |
os | 1460 |
hospital | 1447 |
mean | 1442 |
increase | 1440 |
tested | 1426 |
autologous | 1426 |
ci | 1422 |
products | 1416 |
dna | 1413 |
diagnosis | 1408 |
early | 1404 |
children | 1404 |
function | 1402 |
included | 1400 |
peripheral | 1398 |
period | 1398 |
cov | 1397 |
important | 1395 |
platelets | 1388 |
major | 1385 |
molecules | 1379 |
activity | 1366 |
detected | 1359 |
quality | 1356 |
analyzed | 1355 |
production | 1343 |
presence | 1338 |
grade | 1334 |
factor | 1328 |
center | 1325 |
cr | 1320 |
lower | 1313 |
ifn | 1311 |
hematopoietic | 1301 |
normal | 1278 |
regimen | 1268 |
although | 1263 |
syndrome | 1260 |
versus | 1257 |
outcome | 1247 |
serum | 1243 |
receptor | 1238 |
primary | 1230 |
effects | 1223 |
derived | 1220 |
model | 1214 |
unrelated | 1210 |
per | 1209 |
similar | 1206 |
matched | 1205 |
diseases | 1184 |
obtained | 1180 |
long | 1179 |
molecular | 1174 |
collection | 1170 |
rhd | 1170 |
according | 1168 |
available | 1166 |
collected | 1165 |
effective | 1162 |
safety | 1161 |
rejection | 1154 |
process | 1151 |
reactions | 1151 |
tcr | 1151 |
multiple | 1149 |
drug | 1149 |
hct | 1148 |
aml | 1136 |
aim | 1133 |
given | 1133 |
common | 1133 |
addition | 1129 |
whole | 1129 |
free | 1128 |
failure | 1127 |
since | 1114 |
second | 1111 |
lymphocytes | 1107 |
disclosure | 1105 |
evaluated | 1095 |
nk | 1087 |
leukemia | 1085 |
hcv | 1075 |
genes | 1069 |
igg | 1068 |
engraftment | 1064 |
screening | 1064 |
assay | 1063 |
components | 1063 |
approach | 1061 |
standard | 1060 |
medical | 1057 |
several | 1051 |
four | 1050 |
vitro | 1048 |
prophylaxis | 1047 |
prior | 1044 |
pcr | 1042 |
term | 1042 |
vivo | 1041 |
therefore | 1040 |
complete | 1039 |
impact | 1037 |
less | 1033 |
design | 1028 |
lung | 1025 |
either | 1020 |
differences | 1020 |
storage | 1006 |
surface | 1005 |
frequency | 1004 |
possible | 1004 |
alleles | 1003 |
complications | 997 |
mediated | 988 |
liver | 981 |
infected | 980 |
agvhd | 979 |
followed | 975 |
outcomes | 971 |
procedure | 969 |
complex | 965 |
order | 962 |
target | 960 |
cord | 957 |
presented | 955 |
adverse | 950 |
flow | 945 |
cross | 944 |
health | 944 |
ctl | 937 |
influenza | 934 |
known | 929 |
large | 926 |
none | 923 |
count | 922 |
many | 918 |
university | 918 |
status | 916 |
rbcs | 916 |
considered | 914 |
induction | 913 |
reduction | 912 |
demonstrated | 907 |
show | 906 |
previously | 900 |
sample | 899 |
determined | 899 |
expressed | 896 |
rates | 890 |
inflammatory | 888 |
difference | 888 |
th | 887 |
unit | 885 |
novel | 885 |
phase | 884 |
detection | 882 |
cause | 882 |
like | 878 |
information | 874 |
phenotype | 874 |
acid | 870 |
transfusions | 870 |
sequence | 869 |
transplanted | 869 |
atg | 869 |
interest | 864 |
required | 863 |
report | 862 |
result | 855 |
male | 848 |
determine | 848 |
defined | 843 |
abo | 843 |
cohort | 843 |
evidence | 842 |
laboratory | 841 |
recovery | 840 |
immunity | 840 |
chemotherapy | 840 |
asct | 837 |
management | 835 |
events | 832 |
transfused | 832 |
recipient | 830 |
identification | 829 |
revealed | 826 |
mm | 825 |
underwent | 825 |
decreased | 824 |
therapeutic | 822 |
female | 818 |
least | 815 |
dr | 814 |
tests | 814 |
might | 814 |
volume | 814 |
product | 812 |
additional | 807 |
skin | 804 |
whether | 803 |
controls | 803 |
better | 802 |
need | 802 |
changes | 800 |
findings | 800 |
suggest | 799 |
weeks | 799 |
apheresis | 797 |
predicted | 796 |
tumor | 796 |
still | 796 |
involved | 795 |
lymphoma | 794 |
criteria | 794 |
even | 791 |
infectious | 788 |
national | 784 |
reaction | 783 |
vaccines | 783 |
tissue | 782 |
selected | 781 |
five | 778 |
allele | 778 |
score | 778 |
highly | 775 |
selection | 771 |
bacterial | 770 |
described | 769 |
value | 767 |
identify | 766 |
provide | 765 |
aims | 765 |
iv | 765 |
refractory | 765 |
cellular | 764 |
cytokine | 763 |
healthy | 762 |
genetic | 761 |
renal | 761 |
remission | 759 |
previous | 757 |
dl | 757 |
old | 756 |
assays | 756 |
donations | 754 |
improved | 754 |
loss | 754 |
life | 754 |
efficacy | 753 |
measured | 753 |
individuals | 753 |
memory | 751 |
hbv | 751 |
reactive | 748 |
dependent | 747 |
evaluate | 747 |
cancer | 743 |
association | 742 |
occurred | 741 |
haploidentical | 738 |
rh | 737 |
iron | 737 |
research | 735 |
procedures | 734 |
died | 726 |
whereas | 724 |
average | 724 |
co | 724 |
symptoms | 723 |
csf | 715 |
lymphocyte | 713 |
care | 710 |
current | 709 |
line | 708 |
values | 706 |
specificity | 705 |
limited | 704 |
confirmed | 703 |
hr | 700 |
hb | 700 |
achieved | 699 |
covid | 698 |
amino | 697 |
small | 696 |
culture | 695 |
toxicity | 690 |
region | 688 |
cgvhd | 684 |
centers | 684 |
rna | 683 |
medicine | 680 |
deficiency | 678 |
summary | 677 |
active | 677 |
death | 674 |
processing | 674 |
bm | 668 |
activated | 666 |
secondary | 665 |
recent | 664 |
despite | 664 |
neutrophil | 662 |
restricted | 661 |
source | 659 |
presentation | 658 |
adult | 658 |
proliferation | 655 |
often | 655 |
retrospective | 654 |
stored | 652 |
studied | 650 |
protocol | 646 |
receiving | 645 |
various | 644 |
assessed | 640 |
concentration | 640 |
prediction | 640 |
functional | 637 |
six | 634 |
introduction | 633 |
combination | 632 |
ab | 630 |
especially | 628 |
prevalence | 627 |
investigated | 626 |
respiratory | 626 |
established | 625 |
models | 625 |
last | 620 |
systems | 620 |
populations | 619 |
anemia | 616 |
containing | 615 |
experience | 614 |
work | 614 |
progression | 614 |
family | 613 |
viruses | 613 |
recently | 612 |
decrease | 611 |
isolated | 610 |
cytokines | 609 |
mouse | 609 |
administration | 608 |
stimulation | 608 |
interaction | 608 |
types | 608 |
chimerism | 607 |
absence | 606 |
cytometry | 606 |
mechanisms | 603 |
rare | 603 |
poor | 603 |
cytotoxic | 602 |
kidney | 602 |
evaluation | 601 |
parameters | 601 |
support | 600 |
mutations | 599 |
needed | 598 |
reactivation | 597 |
min | 597 |
reduce | 596 |
set | 595 |
women | 594 |
currently | 594 |
finding | 593 |
transplants | 592 |
weight | 591 |
able | 589 |
doses | 589 |
autoimmune | 588 |
haplo | 588 |
improve | 586 |
seen | 584 |
weak | 583 |
ric | 581 |
characteristics | 581 |
review | 580 |
residues | 579 |
hours | 579 |
iii | 579 |
ability | 578 |
chain | 577 |
infusion | 577 |
conditions | 575 |
generated | 574 |
pediatric | 574 |
relapsed | 573 |
myeloablative | 573 |
individual | 573 |
induce | 570 |
independent | 569 |
good | 568 |
sequences | 567 |
trial | 567 |
ratio | 566 |
intensity | 566 |
ebv | 565 |
initial | 564 |
cyclophosphamide | 564 |
regulatory | 562 |
increasing | 561 |
made | 560 |
contrast | 559 |
comparison | 557 |
countries | 557 |
general | 554 |
majority | 554 |
cost | 553 |
strategy | 552 |
caused | 551 |
reactivity | 551 |
resulted | 550 |
drugs | 548 |
surgery | 548 |
tlr | 547 |
recognition | 546 |
receptors | 545 |
month | 544 |
safe | 543 |
systemic | 542 |
include | 542 |
strategies | 542 |
structure | 540 |
conflict | 540 |
main | 540 |
remains | 539 |
organ | 539 |
expressing | 538 |
improvement | 538 |
subjects | 538 |
develop | 537 |
release | 537 |
hepatitis | 536 |
produced | 535 |
lack | 534 |
diagnosed | 534 |
part | 534 |
prospective | 534 |
hpa | 534 |
via | 532 |
frequent | 531 |
practice | 531 |
partial | 531 |
form | 530 |
routine | 530 |
regimens | 524 |
identical | 524 |
myeloid | 522 |
pathway | 522 |
correlation | 521 |
ph | 521 |
sensitivity | 519 |
bank | 518 |
affinity | 518 |
direct | 518 |
characterized | 518 |
typing | 516 |
vaccination | 516 |
lines | 516 |
protection | 515 |
growth | 515 |
pathogen | 514 |
service | 514 |
analyses | 512 |
mechanism | 511 |
dc | 511 |
tnf | 510 |
program | 509 |
combined | 509 |
grafts | 508 |
site | 507 |
cy | 506 |
change | 505 |
sibling | 503 |
times | 501 |
numbers | 501 |
molecule | 499 |
monoclonal | 499 |
mutation | 497 |
auto | 496 |
undergoing | 496 |
cumulative | 495 |
us | 494 |
drb | 492 |
history | 490 |
plt | 490 |
assess | 488 |
course | 488 |
indicate | 488 |
percentage | 488 |
mobilization | 488 |
distribution | 487 |
alternative | 487 |
coronavirus | 486 |
interactions | 483 |
generation | 483 |
clones | 483 |
likely | 483 |
membrane | 483 |
depletion | 482 |
setting | 482 |
mrd | 482 |
nrm | 482 |
furthermore | 480 |
regions | 480 |
automated | 479 |
inflammation | 477 |
markers | 476 |
applied | 473 |
allograft | 472 |
lead | 472 |
pt | 472 |
body | 469 |
key | 469 |
malignancies | 469 |
later | 468 |
monocytes | 468 |
mds | 467 |
dli | 466 |
end | 465 |
performance | 463 |
stable | 462 |
ra | 462 |
rapid | 462 |
calculated | 461 |
prevent | 461 |
implementation | 457 |
onset | 457 |
macrophages | 456 |
subsequent | 455 |
capacity | 455 |
duration | 454 |
resulting | 454 |
another | 454 |
hospitals | 453 |
international | 453 |
provided | 451 |
recognized | 450 |
nat | 450 |
causes | 450 |
id | 449 |
disorders | 448 |
done | 448 |
shows | 448 |
short | 448 |
future | 447 |
assessment | 447 |
pr | 447 |
agents | 446 |
monitoring | 446 |
week | 446 |
alone | 444 |
clinically | 444 |
indicated | 444 |
wt | 443 |
statistical | 443 |
stage | 441 |
necessary | 440 |
late | 439 |
immunosuppression | 439 |
variants | 439 |
linked | 437 |
neutrophils | 437 |
antigenic | 436 |
suggesting | 436 |
pulmonary | 436 |
leukocyte | 436 |
busulfan | 435 |
hbsag | 435 |
affected | 435 |
mainly | 434 |
full | 433 |
now | 433 |
recombinant | 433 |
relevant | 432 |
sequencing | 432 |
critical | 432 |
effector | 432 |
injury | 431 |
igm | 431 |
statistically | 431 |
trm | 430 |
arthritis | 429 |
features | 427 |
moreover | 425 |
regarding | 424 |
basis | 424 |
regulation | 424 |
self | 424 |
examined | 424 |
hemoglobin | 423 |
mild | 423 |
exposure | 422 |
stimulated | 422 |
administered | 421 |
essential | 421 |
immunization | 419 |
pbsc | 418 |
services | 418 |
concentrates | 418 |
greater | 417 |
fold | 416 |
influence | 416 |
application | 415 |
myeloma | 415 |
investigate | 415 |
ng | 415 |
side | 414 |
reconstitution | 414 |
occur | 414 |
best | 414 |
component | 414 |
analysed | 414 |
structural | 412 |
leading | 412 |
double | 412 |
trials | 412 |
correlated | 411 |
ifitm | 410 |
bacteria | 410 |
strong | 409 |
tolerance | 409 |
towards | 409 |
spike | 409 |
murine | 408 |
multivariate | 408 |
particular | 407 |
demonstrate | 407 |
help | 406 |
gamma | 406 |
must | 406 |
baseline | 405 |
final | 404 |
every | 403 |
staff | 403 |
centre | 403 |
cardiac | 403 |
event | 403 |
panel | 402 |
st | 401 |
optimal | 401 |
finally | 400 |
protective | 398 |
severity | 398 |
knowledge | 397 |
taken | 397 |
processed | 397 |
ms | 397 |
pc | 397 |
involvement | 397 |
guidelines | 396 |
particularly | 396 |
prepared | 396 |
natural | 395 |
complication | 395 |
step | 395 |
successful | 395 |
sites | 395 |
residual | 393 |
mixed | 393 |
experimental | 393 |
carried | 393 |
immunological | 393 |
usually | 393 |
estimated | 392 |
conventional | 392 |
ten | 392 |
counts | 392 |
tbi | 392 |
fludarabine | 391 |
hbc | 391 |
across | 391 |
institute | 391 |
date | 391 |
point | 391 |
local | 390 |
potentially | 390 |
central | 390 |
conducted | 389 |
fever | 389 |
mismatched | 389 |
seven | 389 |
pathogens | 388 |
pfs | 388 |
oral | 388 |
comparable | 387 |
expansion | 387 |
genotype | 387 |
database | 386 |
ha | 386 |
play | 385 |
reports | 385 |
expected | 384 |
strains | 383 |
sle | 382 |
solution | 382 |
hematological | 382 |
ae | 381 |
daily | 381 |
fresh | 380 |
appropriate | 380 |
department | 379 |
bmt | 377 |
size | 377 |
mud | 376 |
tool | 376 |
consecutive | 376 |
vod | 375 |
genome | 375 |
declare | 374 |
pb | 374 |
malignant | 373 |
consisted | 373 |
january | 372 |
technique | 372 |
ferritin | 371 |
genotyping | 371 |
alive | 371 |
efficient | 371 |
distinct | 370 |
together | 369 |
developing | 369 |
adults | 368 |
eight | 368 |
proportion | 367 |
sera | 367 |
transmission | 366 |
published | 366 |
ligand | 366 |
third | 365 |
die | 363 |
retrospectively | 362 |
cultures | 361 |
susceptibility | 360 |
intracellular | 360 |
complement | 360 |
objective | 359 |
differentiation | 359 |
targets | 358 |
morbidity | 357 |
enhanced | 357 |
depleted | 357 |
diagnostic | 357 |
spleen | 357 |
nothing | 357 |
kir | 357 |
frequently | 356 |
pattern | 356 |
detect | 356 |
state | 356 |
highest | 356 |
added | 355 |
enzyme | 355 |
csa | 354 |
sepsis | 354 |
young | 353 |
gp | 353 |
bleeding | 353 |
experienced | 353 |
dendritic | 353 |
elisa | 351 |
signaling | 350 |
option | 349 |
treg | 349 |
marker | 349 |
sd | 349 |
ffp | 349 |
technology | 349 |
complexes | 348 |
plus | 348 |
approximately | 347 |
humans | 346 |
index | 346 |
relative | 346 |
provides | 346 |
sex | 346 |
car | 346 |
challenge | 346 |
ex | 344 |
males | 344 |
suggested | 344 |
formation | 344 |
designed | 344 |
variable | 343 |
apoptosis | 343 |
next | 343 |
moderate | 343 |
series | 342 |
suggests | 342 |
inhibitor | 342 |
gel | 342 |
immunodeficiency | 342 |
immunogenicity | 342 |
others | 341 |
subsets | 340 |
length | 340 |
biopsy | 340 |
variant | 339 |
started | 339 |
serological | 339 |
predict | 339 |
glycoprotein | 339 |
domain | 338 |
immunosuppressive | 338 |
serious | 338 |
experiments | 338 |
interferon | 337 |
inhibition | 336 |
staining | 336 |
training | 336 |
useful | 335 |
concentrations | 335 |
remained | 335 |
mrna | 334 |
authors | 334 |
females | 334 |
der | 333 |
profile | 333 |
elevated | 333 |
targeting | 333 |
nd | 332 |
importance | 332 |
lesions | 332 |
thrombocytopenia | 332 |
validation | 331 |
animals | 331 |
successfully | 331 |
except | 331 |
wb | 330 |
processes | 328 |
pcs | 328 |
presenting | 328 |
contribute | 328 |
tm | 327 |
reference | 327 |
ct | 327 |
resistance | 327 |
immunogenic | 327 |
fully | 326 |
tissues | 326 |
terms | 325 |
yet | 325 |
multi | 325 |
innate | 325 |
quantitative | 325 |
randomized | 325 |
melphalan | 324 |
remaining | 324 |
content | 324 |
variation | 324 |
fetal | 324 |
supply | 323 |
wbc | 323 |
compatible | 323 |
delivery | 322 |
ebmt | 322 |
responsible | 321 |
older | 321 |
infused | 321 |
beta | 321 |
benefit | 320 |
foxp | 318 |
acids | 318 |
controlled | 318 |
compare | 318 |
pathogenesis | 318 |
understanding | 317 |
see | 317 |
extensive | 317 |
circulating | 317 |
delayed | 317 |
aged | 316 |
immunoglobulin | 316 |
longer | 316 |
deficient | 316 |
ecp | 316 |
represent | 316 |
regression | 316 |
mononuclear | 315 |
resolution | 315 |
corresponding | 315 |
steroid | 314 |
epithelial | 314 |
world | 314 |
prevention | 314 |
allosct | 313 |
approaches | 313 |
maintenance | 313 |
express | 311 |
advanced | 311 |
targeted | 311 |
bind | 310 |
preparation | 310 |
pool | 309 |
techniques | 309 |
produce | 308 |
underlying | 308 |
irradiation | 307 |
functions | 307 |
software | 307 |
en | 306 |
way | 306 |
affect | 305 |
comparing | 305 |
led | 304 |
scores | 304 |
aa | 304 |
heart | 303 |
interestingly | 303 |
investigation | 303 |
medium | 302 |
real | 302 |
progressive | 302 |
biopsies | 302 |
pregnancy | 302 |
consistent | 301 |
repertoire | 301 |
inhibitors | 301 |
transfer | 301 |
directed | 301 |
dat | 300 |
minimal | 300 |
indicating | 300 |
survey | 300 |
signs | 299 |
prognosis | 299 |
ns | 298 |
fact | 298 |
occurs | 298 |
allows | 297 |
kit | 297 |
require | 297 |
agent | 296 |
conserved | 296 |
yield | 295 |
unknown | 295 |
cultured | 294 |
relatively | 294 |
mer | 294 |
fi | 293 |
bu | 293 |
properties | 293 |
tacrolimus | 293 |
pools | 293 |
unique | 292 |
predictive | 292 |
twenty | 292 |
generally | 292 |
subsequently | 292 |
screen | 292 |
damage | 292 |
contamination | 291 |
implemented | 291 |
amount | 290 |
significance | 289 |
cyclosporine | 289 |
frozen | 288 |
pro | 288 |
maternal | 288 |
half | 288 |
load | 288 |
european | 287 |
risks | 287 |
context | 287 |
frequencies | 287 |
replication | 286 |
wide | 285 |
temperature | 285 |
hpv | 284 |
areas | 283 |
certain | 283 |
signal | 283 |
filtration | 282 |
requirements | 282 |
mmf | 282 |
tools | 282 |
cutaneous | 282 |
diversity | 282 |
polymorphisms | 281 |
seems | 281 |
literature | 281 |
occurrence | 281 |
ucb | 280 |
nhl | 280 |
institution | 279 |
materials | 279 |
phenotypes | 279 |
ta | 278 |
purified | 278 |
december | 278 |
documented | 278 |
reviewed | 278 |
divided | 278 |
area | 278 |
nine | 278 |
biological | 277 |
directly | 277 |
already | 276 |
enrolled | 276 |
resistant | 276 |
histocompatibility | 276 |
prognostic | 276 |
solid | 275 |
titer | 275 |
hemolytic | 275 |
preliminary | 274 |
remain | 274 |
confirm | 274 |
dcs | 274 |
problem | 273 |
alpha | 273 |
transcription | 273 |
purpose | 273 |
sensitive | 273 |
receive | 272 |
relationship | 272 |
subset | 271 |
intestinal | 270 |
clearance | 270 |
degree | 270 |
scid | 270 |
escape | 270 |
regular | 269 |
rapidly | 269 |
species | 269 |
failed | 269 |
msc | 269 |
appears | 269 |
almost | 269 |
allow | 269 |
bound | 269 |
represents | 268 |
neutropenia | 268 |
scale | 268 |
endothelial | 268 |
intensive | 268 |
requires | 267 |
interval | 267 |
excluded | 267 |
maximum | 266 |
ag | 266 |
effectiveness | 266 |
hemolysis | 266 |
alloantibodies | 266 |
ig | 266 |
points | 266 |
rhce | 266 |
scd | 266 |
structures | 266 |
means | 265 |
efficiency | 265 |
candidate | 265 |
reached | 265 |
strain | 265 |
pregnant | 265 |
availability | 265 |
granulocyte | 264 |
commonly | 264 |
transgenic | 264 |
iga | 264 |
registry | 263 |
origin | 263 |
existing | 263 |
alloimmunization | 263 |
along | 263 |
iu | 263 |
cluster | 262 |
become | 262 |
ptcy | 262 |
prolonged | 262 |
needs | 262 |
pooled | 262 |
hematologic | 261 |
additionally | 261 |
detectable | 261 |
gender | 261 |
rather | 261 |
make | 261 |
clear | 260 |
manual | 260 |
strongly | 259 |
exposed | 258 |
tuberculosis | 258 |
reducing | 258 |
trend | 258 |
states | 258 |
mscs | 258 |
recurrent | 258 |
recommended | 257 |
activities | 257 |
salvage | 256 |
deferral | 256 |
rt | 256 |
irradiated | 256 |
immunology | 256 |
material | 255 |
hematology | 255 |
secretion | 255 |
achieve | 254 |
inactivation | 254 |
much | 254 |
gag | 254 |
predictions | 254 |
larger | 254 |
patterns | 253 |
noted | 253 |
incubated | 253 |
polymorphism | 253 |
analyze | 253 |
increases | 253 |
organs | 252 |
cryopreserved | 252 |
pd | 252 |
specifically | 252 |
around | 252 |
forms | 252 |
reverse | 252 |
ccr | 251 |
search | 251 |
reasons | 251 |
probability | 251 |
tumors | 251 |
allowed | 251 |
invasive | 250 |
titers | 250 |
episodes | 250 |
soluble | 250 |
promising | 249 |
intermediate | 248 |
potent | 247 |
server | 247 |
leads | 247 |
example | 247 |
allografts | 246 |
pneumonia | 246 |
pg | 246 |
sufficient | 245 |
expanded | 245 |
adaptive | 244 |
determination | 244 |
screened | 244 |
modified | 244 |
banks | 244 |
proposed | 243 |
repeated | 243 |
percent | 242 |
mature | 242 |
persistent | 242 |
humoral | 241 |
minutes | 241 |
viability | 241 |
condition | 241 |
ad | 241 |
pathways | 241 |
antiviral | 240 |
continuous | 240 |
therapies | 240 |
measures | 240 |
mass | 240 |
surgical | 240 |
monitored | 239 |
monocyte | 239 |
tx | 238 |
vector | 238 |
feasible | 238 |
top | 238 |
education | 238 |
contact | 237 |
access | 237 |
incubation | 237 |
device | 237 |
lymph | 237 |
collections | 236 |
mostly | 236 |
exon | 235 |
inventory | 235 |
arm | 235 |
global | 235 |
cycle | 235 |
helper | 235 |
supported | 234 |
gut | 234 |
rituximab | 234 |
far | 234 |
animal | 234 |
consensus | 234 |
recognize | 233 |
intravenous | 233 |
appear | 233 |
tube | 233 |
immunized | 233 |
ligands | 232 |
log | 232 |
variables | 232 |
requiring | 232 |
und | 232 |
steps | 232 |
bc | 231 |
curative | 231 |
interleukin | 231 |
observation | 231 |
reagents | 231 |
flu | 230 |
suppression | 230 |
perform | 230 |
validated | 230 |
globulin | 230 |
difficult | 229 |
lps | 229 |
internal | 229 |
des | 229 |
measure | 229 |
del | 229 |
protocols | 229 |
reagent | 228 |
transmitted | 228 |
po | 228 |
policy | 228 |
usage | 228 |
repeat | 228 |
indications | 228 |
pain | 227 |
maintained | 227 |
extended | 227 |
balb | 227 |
tregs | 227 |
country | 227 |
candidates | 227 |
thalassemia | 226 |
includes | 226 |
stat | 226 |
dysfunction | 226 |
objectives | 226 |
physical | 226 |
dfs | 225 |
oxygen | 225 |
europe | 225 |
beam | 225 |
capable | 225 |
ensure | 225 |
brain | 225 |
cns | 224 |
usa | 224 |
immunotherapy | 224 |
inhibitory | 224 |
acquired | 224 |
density | 223 |
describe | 223 |
terminal | 223 |
place | 223 |
completed | 223 |
treatments | 223 |
genotypes | 223 |
differ | 223 |
nm | 223 |
germany | 223 |
plerixafor | 222 |
core | 222 |
pbmcs | 222 |
contained | 222 |
initially | 221 |
emerging | 221 |
coagulation | 221 |
ca | 221 |
cb | 221 |
albumin | 220 |
msd | 220 |
million | 220 |
indicates | 220 |
cold | 220 |
replacement | 220 |
standards | 220 |
nature | 219 |
synthesis | 219 |
uk | 219 |
problems | 218 |
tma | 218 |
ongoing | 218 |
vascular | 218 |
algorithm | 218 |
encoding | 218 |
version | 218 |
haematopoietic | 218 |
absolute | 218 |
matching | 217 |
pressure | 217 |
clusters | 217 |
supplementary | 217 |
glucose | 216 |
adequate | 216 |
classified | 216 |
fraction | 216 |
macrophage | 216 |
entire | 215 |
leukocytes | 215 |
suitable | 215 |
regional | 215 |
classical | 215 |
methotrexate | 215 |
yrs | 215 |
humanized | 215 |
earlier | 215 |
light | 214 |
hl | 214 |
deletion | 214 |
recorded | 214 |
lilrb | 214 |
bl | 214 |
ce | 214 |
cytotoxicity | 213 |
recruitment | 213 |
specimens | 213 |
lfs | 212 |
allohsct | 212 |
contain | 212 |
nkg | 212 |
voluntary | 212 |
completely | 212 |
hypothesis | 212 |
es | 211 |
starting | 211 |
providing | 211 |
network | 211 |
neutralizing | 210 |
sp | 210 |
pp | 210 |
project | 210 |
linear | 210 |
genomic | 209 |
cml | 209 |
lymphoid | 209 |
errors | 209 |
broad | 209 |
abnormalities | 209 |
goal | 209 |
organization | 208 |
costs | 208 |
people | 207 |
apoptotic | 207 |
discovery | 207 |
respect | 206 |
trauma | 206 |
continued | 206 |
probably | 206 |
malignancy | 206 |
possibility | 206 |
producing | 206 |
elispot | 205 |
differential | 205 |
aimed | 205 |
bag | 205 |
match | 205 |
cfu | 205 |
maturation | 204 |
field | 204 |
public | 204 |
wild | 204 |
find | 204 |
sustained | 203 |
toxic | 203 |
jk | 203 |
anaemia | 203 |
disorder | 203 |
steroids | 203 |
records | 202 |
though | 202 |
ivig | 202 |
rr | 202 |
docking | 202 |
killer | 202 |
men | 202 |
initiation | 202 |
questionnaire | 202 |
regulated | 201 |
energy | 201 |
manner | 201 |
exchange | 201 |
laboratories | 201 |
cycles | 201 |
cxcr | 201 |
efs | 201 |
generate | 201 |
coverage | 200 |
reporting | 200 |
past | 200 |
avoid | 200 |
pairs | 200 |
crucial | 200 |
china | 200 |
icu | 200 |
induces | 200 |
migration | 200 |
met | 200 |
mismatch | 199 |
treat | 199 |
focus | 199 |
donate | 199 |
room | 199 |
er | 199 |
approved | 198 |
threshold | 198 |
members | 198 |
participants | 198 |
rheumatoid | 198 |
injection | 198 |
working | 198 |
respond | 198 |
pbmc | 198 |
introduced | 198 |
promoter | 197 |
survivors | 197 |
false | 197 |
depending | 197 |
allergic | 197 |
position | 197 |
se | 196 |
variability | 196 |
minor | 196 |
selective | 195 |
stability | 195 |
enhance | 195 |
initiated | 195 |
cryopreservation | 195 |
hev | 195 |
necrosis | 195 |
ige | 195 |
metabolic | 195 |
kinase | 195 |
tolerated | 195 |
aplastic | 195 |
similarly | 194 |
hsc | 194 |
robust | 194 |
umbilical | 194 |
tract | 194 |
hand | 194 |
little | 194 |
hepatic | 193 |
clone | 193 |
american | 193 |
marked | 193 |
establish | 193 |
overlapping | 193 |
hence | 193 |
hour | 192 |
newborn | 192 |
apc | 192 |
questions | 192 |
hc | 192 |
extracellular | 191 |
consent | 191 |
inducing | 191 |
agglutination | 191 |
indication | 191 |
neonatal | 191 |
located | 191 |
admission | 191 |
team | 191 |
limit | 190 |
progress | 190 |
gr | 190 |
abstract | 190 |
untreated | 190 |
surveillance | 190 |
intervention | 189 |
univariate | 189 |
altered | 189 |
peak | 189 |
progenitor | 189 |
naive | 189 |
doi | 189 |
incompatibility | 189 |
environment | 189 |
pandemic | 189 |
issue | 188 |
showing | 187 |
synthetic | 187 |
residue | 187 |
prophylactic | 187 |
classification | 187 |
considering | 187 |
lacking | 187 |
washed | 186 |
elements | 186 |
autoantibodies | 186 |
mother | 186 |
le | 186 |
gd | 185 |
ranged | 185 |
transferred | 185 |
widely | 185 |
implicated | 185 |
deaths | 185 |
hhv | 185 |
account | 184 |
throughout | 184 |
los | 184 |
bp | 184 |
thymic | 184 |
fungal | 184 |
employed | 184 |
bd | 184 |
ctls | 184 |
copies | 184 |
domains | 183 |
erythrocyte | 183 |
reason | 183 |
spectrum | 183 |
thereby | 183 |
proven | 183 |
define | 183 |
nan | 183 |
mnc | 182 |
trali | 182 |
bags | 182 |
practices | 182 |
hd | 182 |
haemovigilance | 182 |
dmso | 182 |
registered | 182 |
sarcoidosis | 182 |
fluid | 182 |
eligible | 182 |
silico | 181 |
cytomegalovirus | 181 |
start | 181 |
impaired | 181 |
iedb | 181 |
stages | 181 |
massive | 181 |
primed | 181 |
became | 181 |
understand | 181 |
western | 181 |
commercial | 181 |
islet | 181 |
calcium | 181 |
thymus | 181 |
suspected | 181 |
platform | 181 |
occurring | 180 |
tgf | 180 |
white | 180 |
immunodominant | 180 |
basic | 180 |
measurement | 180 |
emergency | 180 |
effectively | 180 |
threatening | 180 |
united | 180 |
ar | 180 |
whose | 179 |
filter | 179 |
lysis | 179 |
mutant | 179 |
improving | 179 |
mac | 179 |
buffy | 179 |
minimum | 178 |
column | 178 |
concerning | 178 |
technical | 178 |
signals | 178 |
pi | 178 |
referred | 177 |
gi | 177 |
von | 177 |
infiltration | 177 |
characterization | 177 |
engrafted | 177 |
pathogenic | 177 |
adjuvant | 177 |
evolution | 177 |
physicians | 177 |
indirect | 177 |
fluorescence | 177 |
detailed | 177 |
infants | 177 |
immediately | 176 |
diabetes | 176 |
obtain | 176 |
donated | 176 |
leukaemia | 176 |
extracted | 175 |
involving | 175 |
examination | 175 |
elderly | 175 |
pathology | 175 |
act | 175 |
removed | 174 |
july | 174 |
mycophenolate | 174 |
entry | 174 |
el | 173 |
etc | 173 |
nucleotide | 173 |
consisting | 173 |
computational | 173 |
posttransplant | 173 |
labeled | 172 |
manifestations | 172 |
blasts | 172 |
creatinine | 172 |
june | 172 |
ic | 171 |
informed | 171 |
ist | 171 |
thirty | 171 |
twice | 171 |
gastrointestinal | 171 |
serology | 171 |
conclude | 171 |
birth | 171 |
weekly | 171 |
younger | 171 |
sickle | 171 |
ko | 170 |
technologies | 170 |
erythrocytes | 170 |
display | 170 |
causing | 169 |
recovered | 169 |
centres | 169 |
newly | 169 |
dominant | 169 |
media | 169 |
kell | 169 |
malaria | 169 |
success | 168 |
mab | 168 |
chains | 168 |
adjusted | 168 |
march | 168 |
consumption | 168 |
gm | 168 |
ed | 168 |
serologic | 168 |
inhibited | 167 |
chimeric | 167 |
treosulfan | 167 |
plays | 167 |
electronic | 167 |
lupus | 167 |
homozygous | 166 |
nkt | 166 |
tap | 166 |
thiotepa | 166 |
reliable | 166 |
shock | 166 |
base | 166 |
centrifugation | 166 |
implications | 166 |
cm | 165 |
absent | 165 |
explain | 165 |
scientific | 165 |
pet | 165 |
cp | 165 |
estimate | 165 |
october | 165 |
fibrosis | 165 |
mtx | 165 |
asymptomatic | 165 |
driven | 165 |
cohorts | 165 |
excellent | 164 |
issues | 164 |
dynamics | 164 |
close | 164 |
possibly | 164 |
subunit | 164 |
advantage | 164 |
corticosteroids | 164 |
signifi | 163 |
ibd | 163 |
stimulating | 163 |
predicting | 163 |
htlv | 163 |
tpe | 163 |
alloreactive | 163 |
fusion | 163 |
matrix | 163 |
fatal | 162 |
give | 162 |
ifng | 162 |
hodgkin | 162 |
predictors | 162 |
great | 162 |
accepted | 162 |
clearly | 162 |
extent | 162 |
immediate | 162 |
allogenic | 162 |
nf | 162 |
panels | 162 |
variety | 162 |
child | 161 |
chromosome | 161 |
epidermal | 161 |
infusions | 161 |
inclusion | 161 |
ranging | 161 |
transient | 161 |
challenges | 161 |
routinely | 160 |
ahsct | 160 |
promote | 160 |
plts | 159 |
recommendations | 159 |
programs | 159 |
sos | 159 |
fl | 159 |
inkt | 158 |
fc | 158 |
rs | 158 |
ruxolitinib | 158 |
incompatible | 158 |
extremely | 158 |
hospitalization | 158 |
responded | 158 |
biology | 158 |
accumulation | 158 |
cut | 158 |
inhibit | 158 |
www | 158 |
displayed | 157 |
equal | 157 |
equipment | 157 |
action | 157 |
accuracy | 157 |
iat | 157 |
measurements | 157 |
cs | 157 |
volunteers | 157 |
adhesion | 157 |
follows | 157 |
address | 157 |
importantly | 157 |
hypertension | 156 |
resources | 156 |
consists | 156 |
concern | 156 |
haplotype | 156 |
superior | 156 |
banking | 156 |
released | 156 |
special | 156 |
represented | 156 |
kb | 156 |
specifi | 155 |
locus | 155 |
intervals | 155 |
examine | 155 |
november | 155 |
efforts | 155 |
restriction | 155 |
live | 155 |
diverse | 155 |
beyond | 155 |
transport | 155 |
specificities | 155 |
suffering | 155 |
rise | 155 |
crossmatch | 155 |
stress | 155 |
kinetics | 155 |
ec | 155 |
random | 154 |
taking | 154 |
flt | 154 |
focused | 154 |
lt | 154 |
signalling | 154 |
making | 154 |
mobilized | 154 |
stimulate | 154 |
characteristic | 154 |
living | 153 |
african | 153 |
acceptable | 153 |
facs | 153 |
substantial | 153 |
simple | 153 |
water | 153 |
indeed | 153 |
latter | 153 |
abnormal | 153 |
ciita | 153 |
hna | 153 |
scoring | 152 |
amounts | 152 |
decision | 152 |
loci | 152 |
priming | 152 |
gave | 152 |
submitted | 152 |
open | 152 |
autoimmunity | 152 |
haematological | 152 |
antiglobulin | 151 |
japan | 151 |
always | 151 |
society | 151 |
iels | 151 |
hemorrhage | 151 |
ri | 151 |
contains | 151 |
called | 151 |
fibrinogen | 151 |
profiles | 151 |
alterations | 150 |
predictor | 150 |
immunomodulatory | 150 |
mo | 150 |
hbs | 150 |
tumour | 150 |
affects | 150 |
undergo | 150 |
trigger | 150 |
independently | 150 |
ma | 149 |
take | 149 |
systematic | 149 |
simulation | 149 |
identifying | 149 |
nuclear | 149 |
throughput | 149 |
neither | 149 |
rabbit | 149 |
lymphoblastic | 149 |
representing | 148 |
clinic | 148 |
alemtuzumab | 148 |
con | 148 |
choice | 148 |
separate | 148 |
cc | 147 |
error | 147 |
comprehensive | 147 |
oncology | 147 |
run | 147 |
pa | 147 |
accurate | 147 |
immature | 147 |
predominantly | 147 |
april | 146 |
auc | 146 |
mucositis | 146 |
maintain | 146 |
saline | 146 |
compliance | 146 |
burden | 146 |
neg | 146 |
encoded | 145 |
easy | 145 |
aspects | 145 |
bkv | 145 |
dp | 145 |
school | 145 |
tetramer | 145 |
seem | 145 |
discussed | 145 |
reduces | 145 |
depends | 145 |
collagen | 145 |
mc | 145 |
cox | 145 |
subtypes | 145 |
rank | 145 |
rcc | 144 |
preventing | 144 |
worse | 144 |
venous | 144 |
changed | 144 |
jak | 144 |
equivalent | 144 |
plan | 144 |
retention | 144 |
responders | 144 |
colony | 144 |
medication | 144 |
microscopy | 144 |
reveal | 144 |
committee | 143 |
numerous | 143 |
exons | 143 |
considerable | 143 |
affecting | 143 |
nih | 143 |
polyclonal | 143 |
ul | 143 |
demand | 143 |
enriched | 143 |
manufacturing | 143 |
pas | 142 |
upper | 142 |
original | 142 |
interventions | 142 |
journal | 142 |
proliferative | 142 |
bei | 142 |
sources | 142 |
colitis | 142 |
supernatant | 142 |
recurrence | 142 |
lab | 142 |
preprint | 142 |
nodes | 142 |
requirement | 141 |
beneficial | 141 |
utilization | 141 |
seropositive | 141 |
np | 141 |
return | 141 |
conditioned | 141 |
correlate | 141 |
mucosal | 141 |
question | 141 |
reach | 141 |
tnc | 141 |
coli | 141 |
largely | 141 |
typed | 140 |
spontaneous | 140 |
mofetil | 140 |
sequential | 140 |
category | 140 |
forming | 140 |
stained | 140 |
amplification | 140 |
sub | 140 |
sirolimus | 140 |
slightly | 140 |
endogenous | 140 |
admitted | 139 |
nucleic | 139 |
positivity | 139 |
allowing | 139 |
italy | 139 |
categories | 139 |
nevertheless | 139 |
bio | 139 |
true | 139 |
isolation | 138 |
heterozygous | 138 |
integrated | 138 |
separation | 138 |
concept | 138 |
heavy | 138 |
cervical | 138 |
settings | 138 |
favorable | 138 |
diagnostics | 138 |
separated | 138 |
ip | 138 |
dsa | 138 |
sent | 138 |
placebo | 137 |
imaging | 137 |
adoptive | 137 |
markedly | 137 |
exhibited | 137 |
gy | 137 |
worldwide | 137 |
mel | 137 |
subjected | 137 |
tandem | 137 |
thymocytes | 137 |
physician | 137 |
assigned | 137 |
cll | 137 |
relation | 136 |
native | 136 |
cleavage | 136 |
thought | 136 |
particles | 136 |
proved | 136 |
issued | 136 |
mmol | 136 |
correlates | 136 |
periods | 136 |
limiting | 136 |
bcl | 136 |
appeared | 136 |
rat | 135 |
consolidation | 135 |
mit | 135 |
hypersensitivity | 135 |
transduction | 135 |
tc | 135 |
simultaneously | 135 |
sclerosis | 135 |
probable | 135 |
preparations | 135 |
joint | 135 |
resource | 135 |
alloantibody | 135 |
elimination | 135 |
correct | 135 |
fixed | 134 |
metabolism | 134 |
tki | 134 |
performing | 134 |
diffuse | 134 |
note | 134 |
siblings | 134 |
composition | 134 |
diarrhea | 134 |
france | 134 |
histological | 134 |
shared | 134 |
characterize | 134 |
transfected | 133 |
febrile | 133 |
antibiotics | 132 |
tcd | 132 |
ia | 132 |
rd | 132 |
myelodysplastic | 132 |
clonal | 132 |
formed | 132 |
decreasing | 132 |
fetus | 132 |
instead | 131 |
operative | 131 |
allohct | 131 |
associations | 131 |
cardiovascular | 131 |
concentrate | 131 |
primarily | 131 |
amr | 131 |
tcrs | 131 |
unclear | 131 |
serve | 131 |
fy | 131 |
spectra | 131 |
typically | 131 |
efficiently | 131 |
south | 131 |
ones | 130 |
exhibit | 130 |
ill | 130 |
chinese | 130 |
bcr | 130 |
ap | 130 |
bearing | 130 |
ucbt | 130 |
enzymes | 130 |
thawed | 130 |
etoposide | 129 |
universal | 129 |
critically | 129 |
options | 129 |
interact | 129 |
protect | 129 |
community | 129 |
microbial | 129 |
leukemic | 129 |
consequence | 129 |
meet | 129 |
limitations | 128 |
feasibility | 128 |
pe | 128 |
list | 128 |
syphilis | 128 |
subgroups | 128 |
tg | 128 |
novo | 128 |
exact | 128 |
buffer | 127 |
atp | 127 |
defect | 127 |
situation | 127 |
http | 127 |
freezing | 127 |
nod | 127 |
standardized | 127 |
bk | 127 |
cxcl | 127 |
synovial | 127 |
defects | 127 |
consideration | 127 |
lowest | 127 |
putative | 127 |
involves | 127 |
demonstrates | 127 |
salt | 127 |
construct | 126 |
injected | 126 |
closely | 126 |
investigations | 126 |
member | 126 |
fda | 126 |
washing | 126 |
institutions | 126 |
ace | 126 |
susceptible | 126 |
responding | 126 |
influenced | 126 |
mb | 126 |
makes | 125 |
resolved | 125 |
bw | 125 |
hydrogen | 125 |
healthcare | 125 |
determining | 125 |
newborns | 125 |
fast | 125 |
regard | 125 |
dpb | 125 |
multicenter | 125 |
sr | 125 |
sampling | 125 |
neurological | 125 |
mutants | 125 |
created | 125 |
kel | 125 |
rhesus | 125 |
hematocrit | 125 |
lactate | 125 |
woman | 125 |
right | 125 |
establishment | 124 |
viremia | 124 |
react | 124 |
coat | 124 |
gvl | 124 |
septic | 124 |
rccs | 124 |
sets | 124 |
observations | 124 |
proper | 124 |
consequently | 124 |
yr | 124 |
les | 124 |
title | 124 |
facilitate | 124 |
compartment | 124 |
activating | 124 |
killing | 124 |
lungs | 124 |
aggressive | 123 |
conjugated | 123 |
tyrosine | 123 |
fragments | 123 |
dtt | 123 |
sjs | 123 |
lc | 123 |
consider | 123 |
ssp | 123 |
ss | 123 |
asian | 122 |
specimen | 122 |
blocking | 122 |
web | 122 |
september | 122 |
uid | 122 |
ir | 122 |
toward | 122 |
personnel | 122 |
apparent | 122 |
aiha | 122 |
lineage | 122 |
degradation | 122 |
adherence | 122 |
iqr | 121 |
na | 121 |
caucasian | 121 |
antigenicity | 120 |
phenomenon | 120 |
proteasome | 120 |
beginning | 120 |
emergence | 120 |
pbs | 120 |
harvested | 120 |
never | 120 |
communication | 120 |
removal | 120 |
consequences | 120 |
social | 120 |
sha | 120 |
partially | 119 |
situations | 119 |
confidence | 119 |
antifungal | 119 |
heparin | 119 |
adenovirus | 119 |
lmp | 119 |
zikv | 119 |
carrying | 119 |
tac | 119 |
stay | 119 |
doc | 119 |
educational | 119 |
lipid | 119 |
trained | 119 |
mcl | 118 |
insulin | 118 |
parallel | 118 |
positions | 118 |
cytogenetic | 118 |
paired | 118 |
survived | 118 |
back | 118 |
filtered | 118 |
just | 118 |
calcineurin | 118 |
hit | 118 |
attention | 118 |
disseminated | 118 |
dress | 118 |
collect | 117 |
netmhcpan | 117 |
distributed | 117 |
left | 117 |
phosphorylation | 117 |
prospectively | 117 |
determinants | 117 |
liquid | 117 |
benefits | 117 |
varied | 117 |
card | 117 |
hemorrhagic | 117 |
uv | 117 |
regulate | 117 |
dilution | 117 |
edema | 117 |
decline | 117 |
pid | 117 |
rich | 117 |
discussion | 117 |
relevance | 117 |
apcs | 117 |
utilized | 117 |
supernatants | 117 |
vectors | 117 |
transplantations | 116 |
reveals | 116 |
stimulatory | 116 |
sensitized | 116 |
hsp | 116 |
delay | 116 |
achieving | 116 |
org | 116 |
clinicians | 116 |
monitor | 116 |
sc | 116 |
compatibility | 115 |
near | 115 |
rest | 115 |
august | 115 |
antibiotic | 115 |
mandatory | 115 |
endpoint | 115 |
roles | 115 |
activate | 115 |
hsv | 115 |
mri | 115 |
extraction | 115 |
medications | 115 |
ld | 115 |
mentioned | 115 |
besides | 115 |
abbott | 115 |
guide | 115 |
combinations | 115 |
variations | 115 |
strength | 115 |
appearance | 115 |
discontinued | 115 |
easily | 114 |
grouping | 114 |
erap | 114 |
kidneys | 114 |
persistence | 114 |
contribution | 114 |
symptomatic | 114 |
chemokine | 114 |
mers | 114 |
deferred | 114 |
parasite | 114 |
precursor | 114 |
understood | 114 |
evaluating | 114 |
pilot | 114 |
delta | 114 |
un | 114 |
toxicities | 114 |
lymphocytic | 113 |
gram | 113 |
urine | 113 |
personalized | 113 |
prism | 113 |
programme | 113 |
poorly | 113 |
label | 113 |
accompanied | 113 |
isolates | 113 |
planned | 113 |
polymerase | 113 |
subgroup | 113 |
nearly | 113 |
protease | 113 |
abs | 113 |
bb | 113 |
spread | 113 |
mir | 113 |
man | 113 |
license | 112 |
prp | 112 |
haemoglobin | 112 |
substitution | 112 |
naturally | 112 |
ova | 112 |
courses | 112 |
diminished | 112 |
mesenchymal | 112 |
cdr | 112 |
insufficient | 112 |
suppressive | 112 |
phagocytosis | 112 |